Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleSupplement

Recent Advances in Radiotracers Targeting Novel Cancer-Specific Biomarkers in China: A Brief Overview

Jingming Zhang, Fei Kang, Xiao Wang, Xuejiao Chen, Xing Yang, Zhi Yang and Jing Wang
Journal of Nuclear Medicine May 2024, 65 (Supplement 1) 38S-45S; DOI: https://doi.org/10.2967/jnumed.123.266314
Jingming Zhang
1Department of Nuclear Medicine, Peking University First Hospital, Beijing, China;
2Department of Nuclear Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fei Kang
3State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiao Wang
1Department of Nuclear Medicine, Peking University First Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xuejiao Chen
1Department of Nuclear Medicine, Peking University First Hospital, Beijing, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xing Yang
1Department of Nuclear Medicine, Peking University First Hospital, Beijing, China;
4Department of Central Laboratory, Peking University First Hospital, Beijing, China;
5Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, China;
6International Cancer Institute, Peking University Health Science Center, Beijing, China; and
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhi Yang
5Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, China;
7Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jing Wang
3State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, China;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 65 no. Supplement 1 38S-45S
DOI 
https://doi.org/10.2967/jnumed.123.266314
PubMed 
38719241

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Received for publication October 31, 2023
  • Revision received January 23, 2024
  • Published online May 6, 2024.

Copyright & Usage 
© 2024 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Jingming Zhang*,1,2,
  2. Fei Kang*,3,
  3. Xiao Wang1,
  4. Xuejiao Chen1,
  5. Xing Yang1,4,5,6,
  6. Zhi Yang5,7 and
  7. Jing Wang3
  1. 1Department of Nuclear Medicine, Peking University First Hospital, Beijing, China;
  2. 2Department of Nuclear Medicine, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, China;
  3. 3State Key Laboratory of Holistic Integrative Management of Gastrointestinal Cancers, Department of Nuclear Medicine, Xijing Hospital, Fourth Military Medical University, Xi’an, China;
  4. 4Department of Central Laboratory, Peking University First Hospital, Beijing, China;
  5. 5Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Beijing, China;
  6. 6International Cancer Institute, Peking University Health Science Center, Beijing, China; and
  7. 7Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing, China
  1. For correspondence or reprints, contact Jing Wang (13909245902{at}163.com) or Xing Yang (yangxing2017{at}bjmu.edu.cn).
  1. ↵* Contributed equally to this work.

View Full Text

Statistics from Altmetric.com

Cited By...

  • 1 Citations
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Emerging Paradigms in Genitourinary Cancers: Integrating Molecular Imaging, Hypoxia-Inducible Factor–Targeted Therapies, and Antibody-Drug Conjugates in Renal Cell and Urothelial Carcinomas
    Rana R. McKay, Renu Eapen, Elizabeth M. Wulff-Burchfield, Michael S. Hofman
    American Society of Clinical Oncology Educational Book 2025 45 3

Article usage

Article usage: May 2024 to April 2025

AbstractFullPdf
May 20241618147101
Jun 20248222015
Jul 202440827363
Aug 202418332154
Sep 202417823078
Oct 202412426358
Nov 202411328892
Dec 2024128274150
Jan 202510224074
Feb 20259626072
Mar 20257720174
Apr 20257519096
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 65 (Supplement 1)
Journal of Nuclear Medicine
Vol. 65, Issue Supplement 1
May 1, 2024
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Recent Advances in Radiotracers Targeting Novel Cancer-Specific Biomarkers in China: A Brief Overview
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Recent Advances in Radiotracers Targeting Novel Cancer-Specific Biomarkers in China: A Brief Overview
Jingming Zhang, Fei Kang, Xiao Wang, Xuejiao Chen, Xing Yang, Zhi Yang, Jing Wang
Journal of Nuclear Medicine May 2024, 65 (Supplement 1) 38S-45S; DOI: 10.2967/jnumed.123.266314

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Recent Advances in Radiotracers Targeting Novel Cancer-Specific Biomarkers in China: A Brief Overview
Jingming Zhang, Fei Kang, Xiao Wang, Xuejiao Chen, Xing Yang, Zhi Yang, Jing Wang
Journal of Nuclear Medicine May 2024, 65 (Supplement 1) 38S-45S; DOI: 10.2967/jnumed.123.266314
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Visual Abstract
    • Abstract
    • IMAGING AGENTS FOR CANCER DIAGNOSIS
    • IMAGING AGENTS FOR GUIDING TARGETED THERAPY
    • IMAGING AGENTS FOR VISUALIZING IMMUNE MICROENVIRONMENT
    • CONCLUSION
    • DISCLOSURE
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Advancing Global Nuclear Medicine: The Role and Future Contributions of China
  • Google Scholar

More in this TOC Section

  • Pathway to Approval of Innovative Radiopharmaceuticals in China
  • Clinical Implementation of Total-Body PET in China
Show more Supplement

Similar Articles

Keywords

  • China
  • radiopharmaceuticals
  • cancer-specific biomarkers
  • cancer diagnosis
  • cancer treatment
SNMMI

© 2025 SNMMI

Powered by HighWire